By Carolyn Gregoire — 2020
As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.
Read on neo.life
CLEAR ALL
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
1
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
Interview with Rick Doblin, Ph.D. Founder of psychedelic research group MAPS, as he talks about his experience with Ibogaine and LSD, in order to confront his own shadows and be more effective as a political activist.
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising.
Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.
In this anthology edited by bestselling author Graham Hancock, 22 writers discuss psychedelics and their myriad connections to consciousness. Travel to South America, the American Southwest, outer space, inner space, and back in time to revisit Pahnke's The Good Friday experiment.
Featuring essays and interviews with Timothy Leary, Aldous Huxley, Ram Dass and others, this one-of-a-kind anthology published by the Multidisciplinary Association for Psychedelic Studies (MAPS), includes topics such as the healing use of marijuana and psychedelics for PTSD, anxiety, depression,...
2